Merck & Co., Inc. is 196.8x more valuable than CAPRICOR THERAPEUTICS, INC. by market capitalization ($294.03 B vs $1.49 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CAPR | MRK |
|---|---|---|
| Market cap | $1.49 B | $294.03 B |
| US-listed rank | #2343 | #45 |
| Revenue (latest FY) | $0.00 | $65.01B |
| Net income (latest FY) | -$105.04M | $18.25B |
| Net margin | - | 28.1% |
| P/E (trailing FY) | - | 16.1 |
| SEC filings | 943 | 996 |
Merck & Co., Inc. is 196.8x more valuable than CAPRICOR THERAPEUTICS, INC. by market capitalization ($294.03 B vs $1.49 B).
In their latest fiscal years, CAPRICOR THERAPEUTICS, INC. reported $0.00 in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: CAPRICOR THERAPEUTICS, INC. and Merck & Co., Inc., or browse the full rankings.